Source: Annual Congress 2004 - Pulmonary circulation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Joppa, R. Tkacova, B. Stancak, J. Salagovic, A. Trejbalova (Kosice, Slovakia). Angiotensin-converting enzyme genotype modulates pulmonary artery pressure in COPD. Eur Respir J 2004; 24: Suppl. 48, 3458

Member's Comments

No comment yet.

Related content which might interest you: Polymorphisms in angiotensin converting enzyme gene are associated with risk of development of and disease severity in scleroderma-related pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension Source: Eur Respir J, 51 (6) 1702638; 10.1183/13993003.02638-2017 Year: 2018 Differences in the activity of the angiotensin converting enzyme 2 axis in patients with idiopathic pulmonary arterial hypertension and congenital heart defect related pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Angiotensin-converting enzyme gene polymorphism as a risk factor of high-altitude pulmonary hypertension in Kyrgyz highlanders Source: Eur Respir J 2001; 18: Suppl. 33, 3s Year: 2001 The role of angiotensin converting enzyme gene polymorphism in pulmonary thromboembolism Source: Annual Congress 2004 - Pulmonary embolism Year: 2004 Angiotensin-converting enzyme insertion/deletion gene polymorphism and interstitial pulmonary fibrosis in Iranian population Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005 Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006 Predictors of response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 No association of angiotensin I-converting enzyme gene polymorphism and pulmonary function in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003 Role of Rho-kinase pathway in et-1-induced vasoconstriction in pulmonary artery of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Pulmonary hypertension in COPD Source: Eur Respir Mon 2013; 59: 189-205 Year: 2013 Respiratory function changes in patients with coronary heart disease after long-term treatment course by β-blockers and angiotensin-converting enzyme inhibitors Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004 Relationship of the polymorphism Lys198Asn endothelin-1 gene with COPD and coronary heart disease. Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Current medical therapies in pulmonary arterial hypertension Source: Eur Respir Mon 2012; 57: 26-41 Year: 2012 Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003 HDAC inhibitor quisinostat reduces pulmonary vascular remodeling in experimentally induced pulmonary arterial hypertension Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Angiotensin-converting enzyme genotype and C-reactive protein in patients with COPD Source: Eur Respir J 2007; 29: 816-817 Year: 2007 ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS Source: Eur Respir J 2007; 29: 482-488 Year: 2007 Tissue inhibitor of metalloproteinases-;2 gene polymorphisms in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 748-752 Year: 2001 Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006